This feasibility study investigates the reendothelialization of tissue-engineered heart valves using endothelial progenitor cells derived from patients with valvular disease.
Animal feasibility supports exploring autologous EPC-seeded valves; human efficacy and durability remain untested.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: